Teleflex Incorporated $TFX Holdings Trimmed by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC decreased its position in Teleflex Incorporated (NYSE:TFX) by 24.9% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 13,258 shares of the medical technology company’s stock after selling 4,407 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Teleflex were worth $1,569,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Banque Cantonale Vaudoise acquired a new position in Teleflex in the first quarter worth $27,000. Costello Asset Management INC bought a new position in shares of Teleflex during the 1st quarter worth approximately $28,000. Brooklyn Investment Group boosted its stake in shares of Teleflex by 258.6% during the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 150 shares during the period. Thurston Springer Miller Herd & Titak Inc. lifted its holdings in Teleflex by 242.9% during the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock worth $26,000 after purchasing an additional 153 shares during the last quarter. Finally, Allworth Financial LP raised its holdings in Teleflex by 504.8% in the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company’s stock valued at $34,000 after acquiring an additional 212 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Andrew A. Krakauer acquired 1,000 shares of Teleflex stock in a transaction dated Tuesday, August 5th. The shares were acquired at an average cost of $115.25 per share, for a total transaction of $115,250.00. Following the acquisition, the director owned 7,192 shares of the company’s stock, valued at $828,878. This trade represents a 16.15% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Gretchen R. Haggerty acquired 500 shares of the company’s stock in a transaction on Wednesday, August 6th. The stock was acquired at an average price of $114.75 per share, for a total transaction of $57,375.00. Following the completion of the purchase, the director owned 6,305 shares of the company’s stock, valued at $723,498.75. This trade represents a 8.61% increase in their position. The disclosure for this purchase can be found here. Insiders bought 5,500 shares of company stock valued at $633,590 in the last 90 days. 1.40% of the stock is currently owned by insiders.

Teleflex Price Performance

Shares of NYSE TFX opened at $119.54 on Friday. The company’s 50-day moving average is $124.30 and its 200 day moving average is $124.18. Teleflex Incorporated has a 1 year low of $108.90 and a 1 year high of $241.41. The stock has a market capitalization of $5.28 billion, a P/E ratio of 28.13, a P/E/G ratio of 1.67 and a beta of 1.05. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping analysts’ consensus estimates of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company had revenue of $780.90 million during the quarter, compared to analyst estimates of $771.53 million. During the same period in the previous year, the business earned $3.42 EPS. The firm’s revenue for the quarter was up 4.2% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Friday, August 15th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. Teleflex’s dividend payout ratio is presently 32.00%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on TFX shares. Mizuho boosted their price objective on Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research report on Friday, August 1st. Wells Fargo & Company reduced their target price on Teleflex from $137.00 to $131.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. Zacks Research lowered Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Royal Bank Of Canada increased their price objective on Teleflex from $130.00 to $135.00 and gave the company a “sector perform” rating in a report on Friday, August 1st. Finally, Wall Street Zen lowered Teleflex from a “strong-buy” rating to a “buy” rating in a report on Monday, September 15th. One analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Reduce” and an average price target of $141.57.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.